Ziosoft debuts 3D thin-client system in U.S.

TriMed Staff | | Health Imaging | Artificial Intelligence
Ziosoft, an advanced visualization and analysis software company for medical imaging, is now offering its thin-client based Ziostation for the U.S. market.   

The Ziostation provides a suite of advanced 3D analysis tools and is based on thin-client architecture, requiring no proprietary or specialized hardware components. The Redwood, Calif.-based company said it does not necessitate a separate standalone workstation to supplement its functionality.  

Features of the Ziostation include: scalable, unified architecture including the ability to load-balance case processing; new toolset including vessel/coronary analysis, multi-volume fusion and anatomy-specific automatic segmentation; and customizable user interface and action macros.

TriMed Staff

Related Content

Most popular radiology video interviews on Health Imaging
RamSoft and Alpha Nodus partner to streamline imaging prior authorization processes
GE HealthCare launches new AI-enabled automated breast ultrasound system
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
What radiologists think about using ChatGPT and AI in breast imaging

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.